Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 07, 2026 13:01 ET | Source: King Faisal Prize

Pioneering Scientist Behind Revolutionary Weight-Loss Drugs and Leading Mathematician Honored with 2026 King Faisal Prize

Riyadh, Saudi Arabia, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Professor Svetlana Mojsov was announced this year's King Faisal Prize in Medicine laureate for her groundbreaking discoveries that are...
January 07, 2026 08:00 ET | Source: Imbria Pharmaceuticals Inc.

Imbria Pharmaceuticals Announces Publication of IMPROVE-DiCE Phase 2a Data in Circulation, Demonstrating Ninerafaxstat as a Potential First-in-Class Therapy Targeting Cardiac Energetics in Cardiometabolic Disease

Data provide first human validation of cardiac energetics modulation as a therapeutic target in cardiometabolic heart disease, including heart failure with preserved ejection fraction (HFpEF) In...
January 06, 2026 01:56 ET | Source: MindRank AI Ltd.

MindRank Initiates Phase III "MOBILE" Trial for MDR-001: an Oral GLP-1RA Small Molecule Engineered with AI

MindRank Initiates Phase III "MOBILE" Trial for MDR-001: an Oral GLP-1RA Small Molecule Engineered with AI
January 05, 2026 08:05 ET | Source: Kailera Therapeutics, Inc.

Kailera Therapeutics Appoints Doug Pagán as Chief Financial Officer

Kailera Therapeutics today announced the appointment of Doug Pagán as its Chief Financial Officer.
December 23, 2025 09:00 ET | Source: Kailera Therapeutics, Inc.

Kailera Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference

Kailera Therapeutics will present at the 44th Annual J.P. Morgan Healthcare Conference in January.
December 17, 2025 07:30 ET | Source: PMGC Holdings Inc.

NorthStrive Biosciences Advances to Phase III of AI-Driven Drug Discovery Program Toward Validation of Multiple Potential Drug Compounds & Discoveries

NorthStrive Biosciences Advances to Phase III of AI-Driven Drug Discovery Program Toward Validation of Multiple Potential Drug Compounds & Discoveries
December 10, 2025 09:16 ET | Source: Research and Markets

US Dominates North America Digital Health for Obesity Market, Reaching USD 78.54 Billion by 2032

Dublin, Dec. 10, 2025 (GLOBE NEWSWIRE) -- The "North America Digital Health For Obesity Market Size, Share & Industry Analysis Report By Component (Services, Software, and Hardware), By End-use...
December 01, 2025 11:00 ET | Source: Zealand Pharma

REMINDER: Zealand Pharma’s Capital Markets Day on December 11, 2025

Press release – No. 17 / 2025 REMINDER: Zealand Pharma’s Capital Markets Day on December 11, 2025 Copenhagen, Denmark, December 1, 2025 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a...
November 24, 2025 16:05 ET | Source: Rani Therapeutics, LLC

Rani Therapeutics to Participate in the Evercore Healthcare Conference

SAN JOSE, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...
November 24, 2025 07:00 ET | Source: Biomea Fusion, Inc.

Biomea Fusion to Participate at Upcoming Investor Conferences

SAN CARLOS, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or “Biomea Fusion” or “the Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today...